Granuloma: Clinical Trials

8 trials for Granuloma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 8
Phase 21Completed 1

Follow Granuloma: new trials by email Literature Review of Granuloma trials Research Report on Granuloma

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
Efzofitimod 3 mg/kg, Efzofitimod 5 mg/kg, Placebo - Pulmonary Sarcoidosis
Phase 3CompletedaTyr Pharma, Inc.2682022-09-152026-06-04
Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)
Mepolizumab, cyclophosphamide/azathioprine, Placebo - Eosinophilic Granulomatosis With Polyangiitis
Phase 3CompletedAssistance Publique - Hôpitaux de Paris1022022-05-302026-10-01
Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.
Rituximab, Azathioprine, Placebo-rituximab - Eosinophilic Granulomatosis With Polyangiitis
Phase 3CompletedAssistance Publique - Hôpitaux de Paris982018-03-072025-11-20
Rituximab in Eosinophilic Granulomatosis With Polyangiitis
Rituximab, Placebo-rituximab, Cyclophosphamide - Eosinophilic Granulomatosis With Polyangiitis (EGPA)
Phase 3CompletedAssistance Publique - Hôpitaux de Paris1072016-12-052026-01-15
Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921
Mepolizumab, Prednisolone - Churg-Strauss Syndrome, Eosinophilic Granulomatosis With Polyangiitis
Phase 3CompletedGlaxoSmithKline1002015-04-142024-03-12
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
Doxorubicin, Doxorubicin Hydrochloride, Ifosfamide - Alveolar Soft Part Sarcoma, Angiomatoid Fibrous Histiocytoma
Phase 2 / Phase 3CompletedNational Cancer Institute (NCI)1402014-08-122026-06-17
A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis
Mepolizumab, Placebo - Churg-Strauss Syndrome
Phase 3CompletedGlaxoSmithKline1362014-02-052018-01-31
Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)
corticosteroid and azathioprine, corticosteroid and placebo - MPA, PAN or EGPA With FFS=0
Phase 3CompletedAssistance Publique - Hôpitaux de Paris1142008-05-012025-09-12

Narrower conditions

Churg-Strauss Syndrome (6)  ·  Chondrosarcoma, Extraskeletal Myxoid (1)  ·  Chondrosarcoma, Mesenchymal (1)  ·  Dermatofibrosarcoma (1)  ·  Fibrosarcoma (1)  ·  Fibrosis (1)  ·  Granuloma, Plasma Cell (1)  ·  Histiocytoma, Angiomatoid Fibrous (1)  ·  Histiocytoma, Malignant Fibrous (1)  ·  Inflammation (1)  ·  Leiomyosarcoma (1)  ·  Liposarcoma (1)  ·  Lung Diseases, Interstitial (1)  ·  Lymphoproliferative Disorders (1)

Broader conditions

Hemic and Lymphatic Diseases (7)  ·  Immune System Diseases (7)  ·  Lymphatic Diseases (7)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (6)  ·  Autoimmune Diseases (6)  ·  Cardiovascular Diseases (6)  ·  Lymphoproliferative Disorders (6)  ·  Skin Diseases (6)  ·  Skin Diseases, Vascular (6)  ·  Skin and Connective Tissue Diseases (6)  ·  Vascular Diseases (6)  ·  Systemic Vasculitis (5)  ·  Vasculitis (5)  ·  Nervous System Diseases (2)

Interventions

Azathioprine (3)  ·  mepolizumab (3)  ·  Cyclophosphamide (2)  ·  Rituximab (2)  ·  Adrenal Cortex Hormones (1)  ·  Doxorubicin (1)  ·  Ifosfamide (1)  ·  Prednisolone (1)  ·  Radiation (1)  ·  Radiotherapy (1)  ·  Sodium Chloride (1)  ·  pazopanib (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (4)  ·  GlaxoSmithKline (2)  ·  National Cancer Institute (NCI) (1)  ·  aTyr Pharma, Inc. (1)

Countries

France (7)  ·  United States (4)  ·  Canada (3)  ·  Germany (3)  ·  Japan (3)  ·  United Kingdom (3)  ·  Belgium (2)  ·  Italy (2)  ·  Spain (2)  ·  Brazil (1)  ·  Netherlands (1)  ·  Puerto Rico (1)

Top investigators

Aaron R Weiss (1)  ·  Benjamin Terrier (1)  ·  Lisa Carey (1)  ·  Loic Guillevin, MD, PhD (1)

Results publications

PMID 28514601, PMID 28678392, PMID 31056661, PMID 32702309, PMID 32827353, PMID 34515544, PMID 37523624, PMID 37902990, PMID 40008472, PMID 40720835

NIH funding

2016 (2), 2014 (1), U10CA098543 (1), U10CA180830 (1), U10CA180886 (1)